Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shagufi Nazar
Institution:
Jamia Hamdard
Observed institution:
Jamia Hamdard
ORCID:
0000-0002-4961-747X
Observed ORCID:
0000-0002-4961-747X
OpenAlex ID:
A5017648964
Recent progress of 1,3,4‐oxadiazoles as anticonvulsants: Future horizons
2020
·
Shagufi Nazar
, Nadeem Siddiqui
, et al.
·
Archiv der Pharmazie
·
33
Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking
2020
·
Mukund Jha
, Ozair Alam
, et al.
·
European Journal of Pharmaceutical Sciences
·
22
Design and development of PROTACs: A new paradigm in anticancer drug discovery
2025
·
Vishal Mathur
, Mukund Jha
, et al.
·
Medicine in Drug Discovery
·
15
EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy
2025
·
Shaheen Ali
, Anam Ilyas
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
5
Triazole Scaffold-based DPP-IV Inhibitors for the Management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SAR
2024
·
Saniya Shamim
, Ozair Alam
, et al.
·
Current Topics in Medicinal Chemistry
·
5
Emerging computational and pharmacological study of topiramate: A brief review
2024
·
Asiya Parveen
, Nadeem Siddiqui
, et al.
·
World Journal of Advanced Research and Reviews
·
2
PDF
Conceptual and molecular docking study of newly developed antiepileptic drug cenobamate
2023
·
Anam Ilyas
, Shagufi Nazar
, et al.
·
World Journal of Advanced Research and Reviews
·
2
PDF
Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessment
2026
·
Mukund Jha
, Ozair Alam
, et al.
·
Bioorganic Chemistry
·
1
Click Chemistry in the Design of 1,2,3-Triazole based α-Glucosidase Inhibitors: Emerging Trends and SAR Insights for Type 2 Diabetes Mellitus
2026
·
Md Fazlur Rahman
, Ozair Alam
, et al.
·
Mini-Reviews in Medicinal Chemistry
Breast cancer and kinase modulation: Nutraceuticals as targeted therapeutics for HER2, PI3K/Akt, and MAPK pathways
2026
·
Anam Ilyas
, Shaheen Ali
, et al.
·
Elsevier eBooks
Heterocyclic GABAA Receptor Modulators: Emerging Therapeutic Strategies for Epilepsy Management
2026
·
Shagufi Nazar
, Nadeem Siddiqui
, et al.
·
Chemistry & Biodiversity
Computational study on gabapentin as a potential therapy for partial seizures
2022
·
Shakira
, Anam Ilyas
, et al.
·
World Journal of Biology Pharmacy and Health Sciences
PDF
Show more works
View as search
Works count:
14
Citation count:
85
H-index:
5
I10-index:
3
Year
Topic
Type
